DataKnowledgeCloudtrainingcoordination

AN3CA (Subject)

Taxonomy Id:

Homo sapiens

Taxonomy (Entity type)

Role Id:

cell line ancestor

Subject Role (Entity type)

Project:

LINCS

Project (Entity type)

Granularity:

cell line

Subject Granularity (Entity type)

Disease:

uterine cancer

Disease (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H N03 AZD-9291 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H G03 DMSO Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC ERBB2002 AN3CA 24H K01 lapatinib 10uM.tsv.gz File (Entity type)	A 89.5 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H F01 afatinib 10uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC ERBB2002 AN3CA 24H E03 afatinib 1.11uM.tsv.gz File (Entity type)	A 131 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H I01 lapatinib 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H I03 lapatinib 0.12uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H G01 DMSO Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H D01 DMSO Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H M03 AZD-9291 0.01uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H N03 AZD-9291 0.12uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H G03 DMSO

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC ERBB2002 AN3CA 24H K01 lapatinib 10uM.tsv.gz

File (Entity type)

A 89.5 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H F01 afatinib 10uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC ERBB2002 AN3CA 24H E03 afatinib 1.11uM.tsv.gz

File (Entity type)

A 131 KB file from LINCS produced from OBI:0002965 as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H I01 lapatinib 0.12uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H I03 lapatinib 0.12uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H G01 DMSO

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H D01 DMSO

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 ERBB2002 AN3CA 24H M03 AZD-9291 0.01uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.